Literature DB >> 23663075

Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice.

M Kobayashi1, C Kaneko-Koike, N Abiru, T Uchida, S Akazawa, K Nakamura, G Kuriya, T Satoh, H Ida, E Kawasaki, H Yamasaki, Y Nagayama, H Sasaki, A Kawakami.   

Abstract

Granzyme B (GzmB) and perforin are proteins, secreted mainly by natural killer cells and cytotoxic T lymphocytes that are largely responsible for the induction of apoptosis in target cells. Because type 1 diabetes results from the selective destruction of β cells and perforin deficiency effectively reduces diabetes in non-obese diabetic (NOD) mice, it can be deduced that β cell apoptosis involves the GzmB/perforin pathway. However, the relevance of GzmB remains totally unknown in non-obese diabetic (NOD) mice. In this study we have focused on GzmB and examined the consequence of GzmB deficiency in NOD mice. We found that NOD.GzmB(-/-) mice developed diabetes spontaneously with kinetics similar to those of wild-type NOD (wt-NOD) mice. Adoptive transfer study with regulatory T cell (Treg )-depleted splenocytes (SPCs) into NOD-SCID mice or in-vivo Treg depletion by anti-CD25 antibody at 4 weeks of age comparably induced the rapid progression of diabetes in the NOD.GzmB(-/-) mice and wt-NOD mice. Expression of GzmA and Fas was enhanced in the islets from pre-diabetic NOD.GzmB(-/-) mice. In contrast to spontaneous diabetes, GzmB deficiency suppressed the development of cyclophosphamide-promoted diabetes in male NOD mice. Cyclophosphamide treatment led to a significantly lower percentage of apoptotic CD4(+) , CD8(+) and CD4(+) CD25(+) T cells in SPCs from NOD.GzmB(-/-) mice than those from wt-NOD mice. In conclusion, GzmB, in contrast to perforin, is not essentially involved in the effector mechanisms for β cell destruction in NOD mice.
© 2013 British Society for Immunology.

Entities:  

Keywords:  NOD mice; apoptosis; transgenic/knock-out mice; type 1 diabetes

Mesh:

Substances:

Year:  2013        PMID: 23663075      PMCID: PMC3949628          DOI: 10.1111/cei.12134

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

Review 1.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

Review 2.  Prevention of type 1 diabetes: from the view point of beta cell damage.

Authors:  Eiji Kawasaki; Norio Abiru; Katsumi Eguchi
Journal:  Diabetes Res Clin Pract       Date:  2004-12       Impact factor: 5.602

Review 3.  Granzyme B: pro-apoptotic, antiviral and antitumor functions.

Authors:  Joseph A Trapani; Vivien R Sutton
Journal:  Curr Opin Immunol       Date:  2003-10       Impact factor: 7.486

4.  Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

Authors:  A Amrani; J Verdaguer; B Anderson; T Utsugi; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide.

Authors:  M Harada; S Makino
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

Review 6.  Granzyme B: a natural born killer.

Authors:  Sarah J Lord; Ray V Rajotte; Gregory S Korbutt; R Chris Bleackley
Journal:  Immunol Rev       Date:  2003-06       Impact factor: 12.988

7.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

8.  Accelerated beta-cell destruction in adoptively transferred autoimmune diabetes correlates with an increased expression of the genes coding for TNF-alpha and granzyme A in the intra-islet infiltrates.

Authors:  C Mueller; W Held; M A Imboden; C Carnaud
Journal:  Diabetes       Date:  1995-01       Impact factor: 9.461

9.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01

10.  Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.

Authors:  D Kägi; B Odermatt; P Seiler; R M Zinkernagel; T W Mak; H Hengartner
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

View more
  4 in total

Review 1.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

2.  SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes.

Authors:  Chao-Yuan Hsu; Li-Tzu Yeh; Shin-Huei Fu; Ming-Wei Chien; Yu-Wen Liu; Shi-Chuen Miaw; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

3.  Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

4.  Identification of Key Genes and Pathways in Peripheral Blood Mononuclear Cells of Type 1 Diabetes Mellitus by Integrated Bioinformatics Analysis.

Authors:  Xing Li; Mingyu Liao; Jiangheng Guan; Ling Zhou; Rufei Shen; Min Long; Jiaqing Shao
Journal:  Diabetes Metab J       Date:  2022-04-01       Impact factor: 5.893

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.